Latest

Blood Pressure Paradox: Hypertension Associated with Survival in T2D and HFPatients with comorbid T2D and heart failure may have a "distinct pathophysiology of the heart" say authors of a new study.
Atrial Fibrillation Prevention: A Three-legged StoolA tripartite strategy targets lifestyle change, treats CV risk factors and CV disease, and encourages more global thinking.
Gout and Heart Disease News RoundupSlide show: Evidence for gout's role as a risk factor for heart disease is mixed. New studies add support.
How to Manage Hypertension in End-stage Renal DiseaseHypertension in dialysis patients is very common and often poorly controlled. Here, a short quiz for the cardiology community.
SGLT2 Inhibitors Improve HF, Survival in Clinical T2D PopulationFindings from the REAL-CVD outcomes study reported at ACC.17 suggest class effect for cardioprotection.
Mechanical FallA 72-year-old woman sustains a distal radius fracture during a fall after losing her balance. She denies syncope. What's your ECG read?
FOURIER Clinical Outcomes Trial Results: Center Stage at ACC.17Highly anticipated, the 2-year results support the promise of PCSK9 inhibitors and also highlight important questions.
Stroke Prevention in the Patient with Afib and T2DM: NOACs vs VKAsWhich anticoagulant therapy has the greater absolute benefit in these complex patients?
Hypertension Management Complicated by Hyperkalemia: What's your Rx?Case-based quiz: Test your clinical judgement on optimal hypertension therapy for this complex patient at risk for hyperkalemia.
ACC Statement on Perioperative Anticoagulation: 5 questions to askAnswers to these 5 questions about patient and pending procedure create a pathway to decisions about perioperative anticoagulation.